SEC Form 4 · accession 0001140361-16-068871
BIOMARIN PHARMACEUTICAL INC · BMRN
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Brian Mueller
Officer — VP, Corporate Controller
Period of report
Jun 3, 2016
Accepted (ET)
Jun 7, 2016 · 10:58 am EDT
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001048477
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common Stock | Jun 3, 2016 | F | 376 | $90.00 | D | 14,547 | D |
Table II — derivative securities
No Table II lines on this filing.